A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery

The programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) is a well-established inhibitory immune checkpoint axis in triple-negative breast cancer (TNBC). Growing evidence indicates that tumoral PD-L1 can lead to TNBC development. Although conventional immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Shadbad, Mahdi Abdoli, Safaei, Sahar, Brunetti, Oronzo, Derakhshani, Afshin, Lotfinejad, Parisa, Mokhtarzadeh, Ahad, Hemmat, Nima, Racanelli, Vito, Solimando, Antonio Giovanni, Argentiero, Antonella, Silvestris, Nicola, Baradaran, Behzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391239/
https://www.ncbi.nlm.nih.gov/pubmed/34440380
http://dx.doi.org/10.3390/genes12081206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391239/
https://www.ncbi.nlm.nih.gov/pubmed/34440380
http://dx.doi.org/10.3390/genes12081206

Ejemplares similares